Watit Sontising | Neuroscience | Best Researcher Award

Dr. Watit Sontising | Neuroscience | Best Researcher Award

Dr. Watit Sontising | Icahn school of medicine at mount sinai | United States

Dr. Watit Sontising is a distinguished chemist whose career seamlessly integrates academic scholarship, industrial innovation, and biomedical research. With a foundation built through advanced studies in chemistry, his expertise spans computational modeling, analytical method development, and environmental compliance. His academic contributions include years of teaching and mentoring in general chemistry, fostering critical thinking and practical skills among diverse student groups. Professionally, he has advanced laboratory efficiency in environmental and industrial chemistry while later transitioning into biotechnology and biomedical research. His current postdoctoral work at the Icahn School of Medicine at Mount Sinai exemplifies his interdisciplinary impact, where he pioneers mass spectrometry imaging and metabolomic profiling to explore neurological disorders. Through a robust portfolio of publications and methodological innovations, he has significantly contributed to the fields of crystallography, material science, and spatial metabolomics.

Profile

Google Scholar

Early Academic Pursuits

Dr. Watit Sontising began his academic journey in chemistry with a strong foundation developed during his undergraduate studies in Thailand. His early exposure to chemical sciences sparked a curiosity for understanding molecular interactions and their implications in both natural and applied systems. Pursuing graduate studies in the United States, he advanced his expertise through master’s and doctoral programs in chemistry at the University of California, Riverside. During this time, he immersed himself in research on molecular interactions, computational chemistry, and crystallography, laying the groundwork for a career that bridges theory, experimentation, and application.

Professional Endeavors

His professional trajectory reflects a balance between academia and industry, allowing him to refine skills across diverse environments. At California State University, Fullerton, and later at the University of California, Riverside, he served as a teaching assistant in general chemistry, where he engaged directly with undergraduate students through lectures, laboratory instruction, and mentorship. Following his doctoral studies, he contributed to environmental chemistry as a laboratory manager, spearheading compliance-driven analytical methods, and later transitioned into the biotechnology sector as a research scientist, applying analytical and modeling techniques to sustainable material development. His current role as a postdoctoral fellow in neurology at the Icahn School of Medicine at Mount Sinai demonstrates his interdisciplinary adaptability, integrating chemistry with neuroscience to advance biomedical research.

Contributions and Research Focus

Dr. Sontising’s research has spanned computational chemistry, analytical method development, and biomedical applications. His doctoral work contributed to the understanding of crystal structures, intermolecular forces, and novel phases of elemental and molecular systems. In industry, he developed high-throughput analytical methods that accelerated workflows and improved efficiency in biomaterial research. At Mount Sinai, his focus has shifted toward metabolomics, lipidomics, and mass spectrometry imaging, where he is developing novel methods to study the chemical architecture of the brain. By combining advanced instrumentation with computational pipelines in R and Python, he has been able to elucidate metabolic pathways in neurological disease models, reinforcing the role of chemistry in unraveling complex biological processes.

Scholarly Publications

His contributions to the scientific community are reflected in a body of published work spanning computational chemistry, crystallography, photomechanical materials, polymerization mechanisms, and spatial metabolomics. His publications in journals such as Chemical Science, CrystEngComm, and Physical Review Materials highlight his ability to merge theoretical approaches with practical applications. Recent work in spatial metabolomics protocols has further expanded the methodological toolkit available to researchers studying brain metabolism, representing a bridge between chemical sciences and medical research.

Accolades and Recognition

Throughout his academic and professional career, Dr. Sontising has been recognized for his commitment to both research excellence and teaching impact. His role as a mentor, educator, and scientific contributor has been acknowledged through opportunities to supervise students, lead laboratory teams, and co-author impactful studies. His ability to secure and contribute to grant-funded projects demonstrates not only trust in his expertise but also recognition of his potential to shape innovative research directions.

Impact and Influence

The impact of his work can be seen in multiple spheres—students he has mentored, laboratories he has organized and modernized, and scientific knowledge he has advanced through publications and method development. By linking fundamental chemistry with applied biomedical research, Dr. Sontising has influenced how metabolomics and mass spectrometry are utilized in the study of neurological disorders. His interdisciplinary perspective allows for meaningful collaborations across chemistry, biology, and medicine, creating pathways for innovation that resonate beyond a single discipline.

Legacy and Future Contributions

Looking forward, Dr. Sontising is positioned to make lasting contributions at the intersection of chemistry and neuroscience. His ongoing development of novel imaging and analytical methods will continue to expand the understanding of brain chemistry and its relationship to disease. As an educator, he remains committed to shaping the next generation of scientists by integrating critical thinking, computational literacy, and practical laboratory expertise into the learning process. His legacy will likely be defined by both the scientific advancements he enables and the careers he helps foster, ensuring his influence endures in both the laboratory and the classroom.

Publications

  • Theoretical study on the mechanism and kinetics of ring-opening polymerization of cyclic esters initiated by tin(II) n-butoxide — C. Sattayanon, W. Sontising, J. Jitonnom, P. Meepowpan, W. Punyodom, … — 2014

  • Structural switching in self-assembled metal–ligand helicate complexes via ligand-centered reactions — L.R. Holloway, H.H. McGarraugh, M.C. Young, W. Sontising, G.J.O. Beran, … — 2016

  • Theoretical predictions suggest carbon dioxide phases III and VII are identical — W. Sontising, Y.N. Heit, J.L. McKinley, G.J.O. Beran — 2017

  • Effect of halogen substitution on energies and dynamics of reversible photomechanical crystals based on 9-anthracenecarboxylic acid — T.J. Gately, W. Sontising, C.J. Easley, I. Islam, R.O. Al-Kaysi, G.J.O. Beran, … — 2021

  • Theoretical study of the hydrogen abstraction of substituted phenols by nitrogen dioxide as a source of HONO — A. Shenghur, K.H. Weber, N.D. Nguyen, W. Sontising, F.M. Tao — 2014

  • Effects of alkoxide alteration on the ring-opening polymerization of ε-caprolactone initiated by n-Bu3SnOR: a DFT study — C. Sattayanon, W. Sontising, W. Limwanich, P. Meepowpan, W. Punyodom, … — 2015

  • Theoretical assessment of the structure and stability of the ε phase of nitrogen — W. Sontising, G.J.O. Beran — 2019

  • Combining crystal structure prediction and simulated spectroscopy in pursuit of the unknown nitrogen phase ε crystal structure — W. Sontising, G.J.O. Beran — 2020

  • Protocol for spatial metabolomics and isotope tracing in the mouse brain — W. Sontising, F. Yanchik-Slade, C. Rodriguez-Navas, M.A. Hossen, … — 2025

  • Combining Crystal Structure Prediction and Simulated Spectroscopy to Investigate Challenging High Pressure Phases — W. Sontising — 2020

Conclusion

Dr. Sontising’s career demonstrates a rare combination of scientific versatility, teaching excellence, and interdisciplinary innovation. His ability to move fluidly from theoretical chemistry to practical laboratory applications, and finally to biomedical research, underscores a dynamic approach that bridges multiple fields of science. He continues to shape the future of chemistry and neuroscience by developing novel analytical tools while inspiring the next generation of scientists through mentorship and education. His enduring influence lies in both his contributions to advancing knowledge and his commitment to empowering others, marking him as a researcher and educator of lasting impact.

Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Prof. Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Prof. Shilin Luo, Xiangya Hospital, Central South University, China.

Dr. Shilin Luo is a leading expert in neuropharmacology and medicinal chemistry, with a strong academic background in traditional Chinese medicine and modern pharmacology. His research focuses on the pathogenesis of neurodegenerative diseases and the development of innovative drug therapies. Through his work at Xiangya Hospital, Central South University, and previous research at Emory University, he has made significant contributions to understanding neurological disorders. His studies on animal models and risk genes have paved the way for novel treatment strategies, earning him international recognition.

Profile

Scopus

Orcid

 

🎓 Early Academic Pursuits

Dr. Shilin Luo’s journey into the world of medical science began with a deep-rooted passion for understanding the complexities of neurological diseases. He earned his Bachelor’s degree in Chinese Materia Medica from Shenyang Pharmaceutical University, where he developed a strong foundation in traditional Chinese medicine and pharmacology. With an insatiable thirst for knowledge, he further pursued a Ph.D. in Medicinal Chemistry at China Pharmaceutical University, specializing in the research of active ingredients in natural products. Under the mentorship of Prof. Wencai Ye, a distinguished scholar, Dr. Luo honed his expertise in medicinal chemistry, paving the way for groundbreaking discoveries in neuropharmacology.

👨‍🎓 Professional Endeavors

To deepen his expertise, Dr. Luo embarked on postdoctoral research at Emory University’s School of Medicine in the Department of Pathology and Laboratory Medicine. Working under the esteemed Prof. Keqiang Ye, he focused on neurobiology and neuropharmacology, contributing significantly to the understanding of neurodegenerative diseases. His research provided novel insights into the molecular mechanisms underlying neurological disorders, positioning him as a leading figure in the field. He later took on a pivotal role as a professor in the Department of Neurology at Xiangya Hospital, Central South University, where he continues to mentor young scientists and advance medical research.

🧪 Contributions and Research Focus

Dr. Luo’s research is primarily dedicated to uncovering the pathogenesis of neurodegenerative diseases and developing therapeutic interventions. His work in animal models of pathogenic and risk genes for neurological disorders has been instrumental in identifying potential drug targets. By integrating traditional Chinese medicine with modern pharmacology, he has contributed to the development of innovative neuroprotective agents. His studies on the molecular mechanisms of neuronal degeneration have led to promising advancements in combating conditions such as Alzheimer’s and Parkinson’s disease.

🏆 Accolades and Recognition

Throughout his career, Dr. Luo has been widely recognized for his groundbreaking contributions to neuropharmacology. His research has been published in high-impact scientific journals, earning him international acclaim. His dedication to scientific excellence has garnered prestigious awards, and he is frequently invited to deliver keynote lectures at global conferences. His work continues to inspire fellow researchers, solidifying his reputation as a distinguished scientist in neurological drug development.

🏰 Impact and Influence

Dr. Luo’s impact extends beyond the laboratory, as he actively contributes to the medical community through mentorship and collaboration. His efforts in integrating traditional Chinese medicinal principles with cutting-edge pharmacological approaches have opened new avenues for drug discovery. His research findings have not only influenced academic discourse but have also laid the groundwork for potential clinical applications, bringing hope to patients suffering from neurodegenerative diseases.

⚛️ Legacy and Future Contributions

As a visionary scientist, Dr. Luo continues to push the boundaries of neurological research. His commitment to translational medicine aims to bridge the gap between laboratory discoveries and clinical applications. By fostering interdisciplinary collaborations and mentoring the next generation of researchers, he is shaping the future of neuropharmacology.

 

Publication

  • Disease-modifying therapies for Alzheimer’s disease: Clinical trial progress and opportunity
    Authors: Yujie Zhang, Jie Chen, Yanru Li, Bin Jiao, Shilin Luo
    Year: 2025

 

  • The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential
    Authors: Ruiling Xu, Yuxuan Zhang, Shurui Chen, Yaohui Zeng, Xuan Fu, Ti Chen, Shilin Luo, Xiaojie Zhang
    Year: 2023

 

  • Nonviral delivery systems for antisense oligonucleotide therapeutics
    Authors: Si Huang, Xin-Yan Hao, Yong-Jiang Li, Jun‑Yong Wu, Da-Xiong Xiang, Shilin Luo
    Year: 2022

 

  • The Microglial membrane receptor TREM2 mediates exosome secretion to promote phagocytosis of amyloid‐β by microglia
    Authors: Si Huang, Xiaoli Liao, Junyong Wu, Xiaojie Zhang, Yamin Li, Daxiong Xiang, Shilin Luo
    Year: 2022

 

  • Correction: Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
    Authors: Not explicitly listed
    Year: 2021

 

  • Polygonatum sibiricum Polysaccharides Protect against MPP‐Induced Neurotoxicity via the Akt/mTOR and Nrf2 Pathways
    Authors: Si Huang, Haiyan Yuan, Wenqun Li, Xinyi Liu, Xiaojie Zhang, Daxiong Xiang, Shilin Luo, Guodong Zhang
    Year: 2021

 

  • Bushen-Tiansui Formula Improves Cognitive Functions in an Aβ1–42 Fibril-Infused Rat Model of Alzheimer’s Disease
    Authors: Chenxia Sheng, Panpan Xu, Xinyi Liu, Weijun Peng, Daxiong Xiang, Shilin Luo
    Year: 2020

 

  • Osteogenesis activity of isocoumarin a through the activation of the PI3K-Akt/Erk cascade-activated BMP/RUNX2 signaling pathway
    Authors: Not explicitly listed
    Year: 2019

 

  • Akt Phosphorylates NQO1 and Triggers its Degradation, Abolishing Its Antioxidative Activities in Parkinson’s Disease
    Authors: Shilin Luo, Seong Su Kang, Zhi-Hao Wang, Xia Liu, Julia X Day, Zhiping Wu, Junmin Peng, Daxiong Xiang, Wolfdieter Springer, Keqiang Ye
    Year: 2019

 

  • Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile
    Authors: Not explicitly listed
    Year: 2018

 

Conclusion

Dr. Luo’s unwavering dedication to neurological research continues to shape the future of neuropharmacology. His innovative approach, combining traditional medicinal insights with modern scientific advancements, has the potential to revolutionize drug development for neurodegenerative diseases. As a mentor, researcher, and pioneer in his field, his contributions will leave a lasting impact on both academia and clinical medicine, offering hope for more effective treatments in the years to come.